University of Central Florida

STARS
HIM 1990-2015
2012

Ethanol lock therapy in the treatment and prevention of catheterrelated bloodstream infections
Breanna Anderson
University of Central Florida

Part of the Nursing Commons

Find similar works at: https://stars.library.ucf.edu/honorstheses1990-2015
University of Central Florida Libraries http://library.ucf.edu
This Open Access is brought to you for free and open access by STARS. It has been accepted for inclusion in HIM
1990-2015 by an authorized administrator of STARS. For more information, please contact STARS@ucf.edu.

Recommended Citation
Anderson, Breanna, "Ethanol lock therapy in the treatment and prevention of catheter-related bloodstream
infections" (2012). HIM 1990-2015. 1245.
https://stars.library.ucf.edu/honorstheses1990-2015/1245

ETHANOL LOCK THERAPY IN THE TREATMENT AND PREVENTION OF
CATHETER-RELATED BLOODSTREAM INFECTIONS

by

BREANNA ANDERSON

A thesis submitted in partial fulfillment of the requirements
for the Honors in the Major Program in Nursing
in the College of Nursing
and in The Burnett Honors College
at the University of Central Florida
Orlando, Florida

Spring Term 2012

Thesis Chair: Stephen Heglund, MSN, ARNP

ABSTRACT
Ethanol lock therapy is a novel technique that is being studied for its efficacy in
eradicating catheter related bloodstream infections. A systematic review of interdisciplinary
studies from CINAHL, Medline, Academic Search Premier, Biological Abstracts, and Web of
Knowledge databases was performed. This meta-analysis examined the findings of thirty-five
studies on ethanol lock therapy. Twenty-six of these studies compared ethanol to a placebo and
nine studies performed a direct comparison of ethanol to other agents frequently used in
antimicrobial lock technique. Ethanol lock therapy was shown to be effective as both a
prophylactic therapy and as an active treatment in eradicating biofilms of organisms that
frequently cause catheter-related blood stream infections, including Staphylococcus epidermis,
Staphylococcus aureus, Klebsiella pneumonia, Pseudomonas aeruginosa, E. coli, and Candida
albicans. Ethanol has been shown to have a synergistic effect with several other antimicrobial
agents. The majority of studies examined in this thesis have found that ethanol has equal or
greater efficacy to several antibiotic and antimicrobial agents used in practice and should
therefore be considered for the treatment of catheter-related blood stream infections.
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INTRODUCTION
The mortality rate from catheter-related bloodstream infections is 12-25% (Srinivasan, et
al., 2011). In addition to adversely affecting patient outcomes, catheter-related bloodstream
infections create significant economic cost to the health care system. Treating a single catheterrelated bloodstream infection ranges in cost from $4,000 to $80,235 (Bakke, 2010). Annually,
this amounts to between $296 million and 2.3 billion (Kim, Saunders, & Yousefzadeh, 2010).
This cost will now be entirely funded by hospital organizations, since the Centers for Medicare
and Medicaid will no longer reimburse catheter-related bloodstream infections as of October
2008 (Kim et al.).
There are two main courses of action that can be pursued when a patient develops a
catheter-related bloodstream infection: 1) The catheter can be removed, and 2) attempts can be
made to salvage the catheter. A third option, inaction, is not a valid option in clinical practice as
it typically results in sepsis and the death of the patient. There is an increase in costs associated
with the replacement of tunneled central lines, as a surgical procedure is needed to place the new
central venous catheter. The probability of adverse outcomes increases with catheter
replacement. Chemotherapy and bone marrow transplantation patients may be
thrombocytopenic and require a delay before reinsertion due to impaired coagulation. Adverse
outcomes and increased costs could be diminished if catheters can be salvaged (Broom et al.,
2008). It is preferable to avoid removing the catheter if possible because of associated costs and
limited access sites in pediatric patients (McGrath et al., 2011).
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Antimicrobial lock therapy is one technique used in salvaging infected catheters.
Antimicrobial lock technique involves filling the lumen of the catheter with an antibiotic or other
antimicrobial agent at a high concentration. The solution is left to dwell in the lumen of the
catheter (Qu, Istivan, Daley, Rouch, & Deighton, 2009). In essence, the solution is “locked” into
the central line for a certain length of time. Ethanol is a potential antimicrobial lock solution that
has been shown to be effective in multiple studies. Ethanol is an antimicrobial lock solution that
works by denaturing microbes on a broad-spectrum level (Sherertz, Boger, Collins, Mason, &
Raad, 2006). Ethanol has a bactericidal effect on both Gram positive and Gram negative bacteria
due to its action of denaturing protein (Broom et al., 2008). Sherertz et al. (2006) conclude that
the chances of resistance developing are “unlikely.” This statement was supported by Opilla,
Kirby, and Edmond (2007), who stated that ethanol lock therapy was unlikely to cause microbial
resistance.
A double-blind randomized trial that compared the prophylactic administration of ethanol
compared to heparinized saline showed the ethanol does have a significant effect in preventing
catheter-related blood stream infections. This study also showed that Gram-negative bacteremia
was susceptible to the effects of ethanol (Sanders et al., 2008). However, a study by Slobbe,
Doorduijn, and Lungtenburg (2010) found that prophylactic ethanol lock solutions instilled for
fifteen minutes daily did not have a significant effect on the reduction of catheter-related
bloodstream infections. The incidence in the experimental group was 0.70 and 1.19 for the
control group per 1,000 catheter days (Slobbe et al.). Ethanol instilled for longer periods of time
has met greater success as a therapeutic measure. Administered in conjunction to systemic
antibiotics, ethanol lock therapy was effective in catheter salvage in pediatric patients (Onland,
Shin, Fustar, Rushing, & Wong, 2006). Both this study and a retrospective study of pediatric
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patients with intestinal failure by Jones et al. (2010) reported no adverse side effects to ethanol
lock therapy. Slobbe et al. did report some adverse effects, none of which were life-threatening.
A study by Crnich, Halfmann, Crone, and Maki (2005) indicated that the integrity of the selected
polyetherune and silicone catheters were not significantly altered by ethanol. Based upon their
findings on ethanol’s efficacy as an individual agent in lock solutions, Sherertz et al. (2006)
hypothesize that a synergistic effect could be achieved by combining antibiotic lock agents with
ethanol.
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PROBLEM
Although the incidence of catheter related bloodstream infections has decreased in the
past decade, the Centers for Disease Control and Prevention (CDC) reports that it is still a
significant problem. Eighteen thousand catheter-related bloodstream infections occurred in 2009
in intensive care units in the United States. Twenty-three thousand catheter- related bloodstream
infections occurred in inpatient wards during the same year. From 2001 data, this amounts to
approximately a 58% reduction (CDC, 2011).
The treatment of catheter-related bloodstream infections with systemic antibiotics alone
has several deficits. Systemic antibiotics are often ineffective in eradicating biofilm-grown
bacteria, and access of the system antibiotics to the catheter lumen may be poor when systemic
antibiotics alone are used. Eradicating the biofilm through systemic antibiotics alone is difficult
given the multi-factorial nature of the biofilm’s resistance. Planktonic organisms released by the
biofilms are killed by systemic antibiotics; however, the organisms embedded in the biofilm are
difficult for the systemic antibiotics to penetrate (Aslam, 2008). Catheter lock technique may be
used (most often in conjunction with systemic antibiotics) to help prevent or treat catheterrelated bloodstream infections. In this technique, the catheter lumen is filled with a high
concentration of an antimicrobial agent during times when it is not in use (Qu et al., 2009).
A study by Polgreen, Beekmann, Diekema, and Sherertz (2010) found that only 19% of
infectious disease consultants had used antimicrobial lock prophylaxis. Antimicrobial lock
therapy is more common, and is often used along with systemic antibiotics in attempts to salvage
catheters. Data collected in the above study found that, among infectious disease consultants
using antimicrobial lock therapy, vancomycin is the most frequently used agent (Polgreen et al.).
4

However, Sherertz et al. (2006) compared the in vitro efficacies of various lock solutions and
found vancomycin to be the least effective with a high risk of microbial resistance. This
demonstrates the need for a more comprehensive comparison among lock agents.
Due to the comparatively high expense of antibiotic lock solutions and the possibility of
increasing microbial resistance, other antimicrobial lock solutions would be preferable (Opilla et
al., 2007). Although the Infectious Diseases Society of America has guidelines for the use of
antibiotic lock solutions to treat catheter-related bloodstream infections, the routine prophylactic
use of antibiotic lock solutions is currently advised against (Kim et al., 2010). However, the
CDC (2011) recommends that practitioners “[u]se prophylactic antimicrobial lock solutions in
patients with long term catheters who have a history of multiple catheter-related bloodstream
infections despite maximal adherence to aseptic technique.” One of the concerns of the
Infectious Diseases Society of America and a major contraindication to the prophylactic use of
antibiotic lock solutions is the risk for microbial resistance (Casey & Elliot, 2010). A study by
Venkatesh, Rong, Raad, and Versalovic (2009) cite the need for non-antibiotic measures against
catheter-related bloodstream infections due to antimicrobial resistance. Ethanol is comparatively
inexpensive: according to Opilla et al. (2007), the 5 milliliter ampules of 98% medical grade
ethyl alcohol costs roughly $10.00. McGrath et al. (2011) estimated the costs of an ethanol lock
to be around $16.00 (McGrath et al.) The cost of a vancomycin flush is roughly $29.40 (Penel &
Yazdanpanah, 2008).
The efficacy demonstrated in the findings of Sanders et al. (2008), Onland et al. (2006),
and Jones et al. (2010), suggest that ethanol may be an efficacious agent in eradicating and
preventing catheter related blood stream infections. If found to be an efficacious agent, it would
be more cost effective than antibiotic lock therapy, as evidenced by the cost efficiency cited by
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McGrath et al. (2011) and Opilla et al. (2007). Furthermore, the Infectious Diseases Society of
America cites the risk of developing resistance as a barrier to the use of prophylactic lock
therapy (Kim et al., 2010). The findings of Sherertz et al. (2006) and Opilla et al. suggest that it
is unlikely that bacteria will develop a resistance to ethanol. The potential benefits of reducing
antimicrobial resistance and cost effectiveness are indicative that ethanol is an agent that
warrants further research in regards to its efficacy in comparison to antibiotic lock therapies
currently used in practice. Ethanol lock therapy may have advantages over antibiotic lock
therapy; however, the primary consideration is ethanol’s efficacy in comparison to existing lock
therapies in preventing catheter related blood stream infection.
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PURPOSE
Is ethanol lock therapy is as effective as antibiotic lock solutions in the treatment and
prevention of catheter-related bloodstream infections? Many other research questions arise in
order to answer this question. Is ethanol effective when used as a prophylactic measure? Lastly,
is ethanol most effective as a single agent or is it more efficacious when used in combination
with other antimicrobial lock agents? The purpose of this thesis is to provide a comprehensive
review of recent literature concerning ethanol lock therapy and its efficacy. This thesis will
review studies comparing the efficacies of ethanol lock therapy to antibiotic lock therapy, and
will also examine whether ethanol is more efficacious when used alone or when used in
conjunction with other antimicrobial lock solutions. A comparison of the therapeutic and
prophylactic efficacies of ethanol and antibiotic lock solutions is necessary to help determine if
ethanol lock therapy is as effective in the treatment and prevention of catheter-related
bloodstream infections and whether this technique should be used in clinical practice.
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METHOD
A review of literature related to central line infection reduction methods including
ethanol lock and antibiotic lock therapies and their respective effects on the prevention and
treatment of catheter-related bloodstream infections has been conducted. Both the therapeutic
and prophylactic effects of ethanol lock therapy have been examined. The literature on antibiotic
lock therapies is substantial. Therefore, the findings of this thesis consider three categories of
studies. The first category compares only single agents (e.g. vancomycin, ciprofloxin, and
rifampicin) to ethanol lock therapy. The second category examines the efficacy of combinations
of various agents (excluding ethanol as a component) into one lock solution compared to ethanol
as a single agent. The third and last category examines studies comparing the efficacy of
combinations of lock agents containing compared to the efficacy of ethanol used as a single
agent. Information was gathered from CINAHL, Medline, Academic Search Premier, Biological
Abstracts, and Web of Knowledge databases. Articles were peer-reviewed and published in
English. Restrictions were not placed on the date of publication. The studies reviewed for this
thesis are interdisciplinary, including but not limited to nursing, and may be conducted in the
United States or internationally.
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FINDINGS
The Effects of Various Agents on Biofilm
A biofilm is formed when free-floating bacterial organisms (planktonic organisms)
adhere to the surface of the catheter. An extracellular polysaccharide matrix is then secreted by
the micro colonies of the bacteria that have begun to form. The matrix accounts for 95% of the
biofilm’s mass, with only 15% actually composed of living cells. Detachment of the living
organisms can occur when the biofilm is overcrowded or if there is insufficient nutritional
support for the biofilm. The planktonic organisms can then create new areas of colonization. The
biofilm creates an environment that is more conductive to the survival of the bacteria. The first
advantage is the polysaccharide matrix, which makes it difficult for antimicrobial agents to reach
the bacteria and penetrate the cell wall. Free-floating organisms do not have this protection, and
are therefore eradicated effectively by systemic antibiotics. The metabolism of bacteria in a
biofilm also changes, giving the biofilm another defense mechanism against antibiotics.
Antibiotics that affect cell wall and protein synthesis will not be as effective against organisms in
a biofilm since the rate of protein and cell wall synthesis is dramatically reduced (Aslam, 2008).
Another mechanism that has been hypothesized to increase the resistance of biofilms to
antibiotics is the relative hypoxic environment. This environment would affect the activity of
antibiotics, reducing the efficacy of the aminoglycoside class of antibiotics in particular (Stewart
& Costerton, 2001). Furthermore, when the biofilm is composed of multiple organisms, the
resistance of the organisms to antimicrobial agents may increase. Protective effects have been
noted when Staphylococcus epidermis and Candida albicans are both part of a biofilm. The yeast
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cells were more resistant to the azole family of antifungals and the efficacy of vancomycin
against the bacteria was decreased due to the presence of the other organism.
Concentrations of up to 1,000-fold of antibiotics are not effective against biofilms due to
these mechanisms of resistance (Aslam, 2008). Due to toxicities and adverse effects from
antibiotic agents, it would not be feasible to give a patient systemic antibiotics in a concentration
great enough to eradicate the biofilm. The catheter-lock technique is used in conjunction to
systemic antibiotics in order to instill a high concentration of antimicrobial solution into the
catheter in order to eradicate the biofilm without systemic side effects.
Choosing an Antimicrobial Lock Agent: Mechanisms of Agents Used for Lock Therapy
As recommended by Berrington and Gould (2001), bactericidal agents are preferable to
bacteriostatic agents for antimicrobial lock therapy. Bacteriostatic agents inhibit bacterial
growth; these agents do not directly kill the cell. In contrast, cells are eradicated directly by
bactericidal agents (Lehne, 2010). As stated above, biofilms are more resistant to antimicrobial
agents that inhibit cell wall synthesis, as the growth rate of the biofilm is reduced in comparison
to that of planktonic organisms (Donlan, 2011). In summary, an agent that can eradicate
biofilms effectively must be able to function in anaerobic conditions and be able to penetrate the
matrix of the biofilm.
According to the Centers for Disease Prevention and Control, there is a high occurrence
of antibiotic resistant organisms in device-related infections (CDC, 2011). Data from 2006-2007
showed that 56% of Staphylococcus aureus were methicillin resistant (MRSA). Resistance of
enterococci was also high, with 80% of E. faecium and 7% of E. faeccalis having a resistance to
vancomycin. Among organisms of Psuedomonas aeruginosa, 30% were resistant to
ceftazodime, 17% were resistant to piperacillin, and 25% were resistant to carbapenems. The
10

rate of isolates resistant to carbapenems was also significant in A.baumannii, for which 29% of
isolates were resistant, and Klebsiella penmonia, for which 10% of isolates were resistant
(Hidron et al., 2008). Although there has been a decrease in the rates of catheter-related
infections caused by Gram-negative organisms, the incidence of multidrug resistant Gramnegative bacteria is increasing (Hidron et al.). The antimicrobial lock solution chosen for
treatment should be based on the causative organism. The most common organisms that cause
catheter-related bloodstream infections are coagulase-negative staphylococci (Hidron et al.). The
second most common cause of device-related infections is Candida. Antibiotic lock therapy is
not as effective against Candida as it is against bacterial organisms since Candida is a fungal
organism. Lock solutions with antifungal agents must be used in order to eradicate Candida
(Hidron et al.). Another common organism is Staphylococcus aureus, which is more common
among dialysis patients (Lederer, Riederlsdorf, & Schiffl, 2007). The rates of enterococcal
catheter-related bloodstream infections are also increasing. According to Mermel et al. (2009)
the appropriate protocol is to first obtain a culture to determine the causative organism. While the
results of the culture are pending, the agents initially used should be effective against Gram
negative bacilli and staphylococci. If the patient has a femoral access, the agent should be
effective against Candida spp. After the results of the culture have been obtained, the regimen
should be modified to treat the specific organism (Mermel et al.).
Mechanisms of antibiotics.
According to the CDC (2011), the most common antibiotic agents currently used in
antibiotic lock therapy are gentamicin, ciprofloxacin, amikacin, minocycline, cefazolin,
ceftazidime, and vancomycin. Donlan (2011) indicates that fluoroquinolones, rifampin, and the
macrolides are among the antibiotics that are more successful in penetrating the biofilm.
11

According to Lehne (2010), there are seven major classes of mechanisms through which
antibiotics work. One of these, suppressing viral replication, is not of concern when considering
catheter-related bloodstream infections. The remaining mechanisms of antibiotics are to inhibit
cell wall synthesis (bacteriostatic or bactericidal), to disrupt the cell membrane (bacteriostatic or
bactericidal), to interfere with synthesis or integrity of bacterial deoxyribonucleic acid (DNA)
and ribonucleic acid (RNA), or to disrupt specific biochemical reactions (Lehne). The macrolides
are broad-spectrum, bacteriostatic inhibitors of protein synthesis (Lehne). Gentamicin and
tobramycin are both aminoglycosides, which are bactericidal inhibitors of protein synthesis.
However, it is important to note that aminoglycosides are effective against Gram-negative
bacteria but not against most Gram-positive bacteria. In addition, anaerobes are not killed by
aminoglycosides (Lehne). Lehne remarks that “[f]or that same reason, aminoglycosides are
inactive against facultative bacteria when these organisms are living under anaerobic conditions”
(Lehne). As previously noted, the anaerobic conditions of the biofilm may lead to resistance to
aminoglycosides (Aslam, 2008). Vancomycin is bactericidal and works by inhibiting cell wall
synthesis. It is not effective against gram-negative bacteria (Lehne). Ciprofloxacin is a
fluoroquinolone that is bactericidal and inhibits bacterial enzymes needed for DNA replication. It
is a broad spectrum agent, but it is not effective against anaerobes (Lehne). The Healthcare
Infection Control Practices Committee is particularly concerned with microbial resistance to
vancomycin. For this reason, it advises that only certain severe cases receive antibiotic lock
therapy containing vancomycin and that it is not a routinely used agent (Donlan). However, the
development of resistance is an issue of concern with all antibiotic agents (Lehne).
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Mechanism of non-antibiotic antimicrobial agents.
Ethanol, trisodium citrate, and taurolidine are other antiseptic, non-antibiotic agents that
have been studied in antimicrobial lock therapy (CDC, 2011). Ethanol works by denaturing
protein (Lehne, 2010). Due to its ability to denature protein, ethanol is effective against both
Gram positive and Gram negative bacteria (Broom et al., 2008). It has a very small molecular
weight and is hydrophilic, which makes penetration of the biofilm possible (Donlan, 2011).
Efficacy of ethanol as an antimicrobial lock agent.
According to Venkatesh et al. (2009), the most frequently causative organisms for
catheter related blood stream infections are Staphylococcus epidermis and Candida albicans.
Other studies examined for this paper examined the effects of ethanol on Methicillin-resistant
Staphylococcus aureus, Methicillin-sensitive Staphylococcus aureus, Methicillin resistant
Staphylococcus epidermis, Psuedomonas aeruginosa , E. coli, Klebsiella pneumonia, and
Staphyloccocous epidermis.
An in vitro study by Henry-Stanley, Shepherd, Wells, and Hess (2009), tested the
efficacy of ethanol against Staphylococcus aureus growing within silastic catheters. The biofilms
were grown in vitro for 48 hours using a nutrient source to imitate a clinical setting. The catheter
segments were then placed in 70% ethanol. The segments were placed in the ethanol for times
varying from five minutes to twenty-four hours, but there was not a significant difference in
results secondary to immersion time. Initial cultures showed that there were no viable bacteria.
The catheter segments were then reattached to the growth medium for 24 hours to test for
regrowth. No regrowth occurred in the ethanol treated segments. Another study by Chambers,
Peddie, and Pithe (2006) showed that exposure to 70% ethanol killed planktonic organisms in
seconds. However, longer dwell times (the amount of time the solution is left in the lumen of the
13

catheter) were needed to eradicated established biofilms. A four hour exposure to 70% ethanol
eradicated all viable cells in in vitro biofilms of Staphylococcus aureus (strain ATCC 25923 and
three clinical isolates), Staphylococcus epidermis (strain ATCC 49134 and three clinical
isolates), E. coli (strain ATCC 25922 and three isolates), Pseudomonas aeruginosa (strain ATCC
27853 and four clinical isolates, Klebsiella pneumonia (three clinical isolates), and Candida
albicans (four clinical isolates). After the cultures were allowed to incubate for 40 hours, there
was regrowth of Candida albicans after 1-2 hours of exposure to the ethanol lock. However,
there was no regrowth after a four hour dwell time (Chambers et al.). Certain isolates of
Klebsiella pneumonia and P. aeruguinosa also required a four hour dwell time to completely
prevent regrowth. All other organisms noted above did not have any regrowth after a one hour
dwell time. A one hour dwell time effectively eradicated all of the organisms in the study and
prevented regrowth for biofilms that were incubated for 16 hours (Chambers et al.).
Ethanol lock therapy appears to be tolerated well by patients, and has been used
successfully in pediatric populations. One retrospective study examined ethanol lock therapy (a
70% concentration) instilled into a central venous catheter as a single agent used in conjunction
with systemic antibiotics for short-term therapy less than or equal to three days (McGrath et al.,
2011). The rate of success in eradicating the catheter related blood stream infections was 86%
with a 78% rate of central line retention and salvage. This study estimated that the eradication
rate using systemic antibiotics alone would be 50% (McGrath et al.). Several other studies
examining the effects of ethanol lock therapy in comparison to a placebo and in clinical practice
are included in Table 1.
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Ethanol Comparisons
Ethanol as single agent compared to other single agents.
An in vitro study by Qu et al. (2009) found that six strains of coagulase-negative
staphylococci were more effectively eradicated by ethanol than by oxacillin, gentamicin,
vancomycin, ciprofloxacin, or rifampin. The minimal effective concentration needed for biofilm
eradication was compared. All cells were killed by ethanol at a 20% concentration. Gentamicin
was the only antibiotic to eradicate the biofilm cells of two strains overnight at a comparatively
high concentration of 10,000 mcg/ml-1. Oxacillin and vancomycin (both at concentrations of
5,000 mcg/ml-1) did not completely kill the cells of the biofilm after an overnight exposure. At a
full 24 hours of exposure, all isolates were sterilized by rifampicin and ciprofloxacin. However,
the concentration of these agents needed to achieve sterilization was comparatively high, ranging
from 32-128 mcg/ml-1 for ciprofloxacin and 256-512 mcg/ml-1 for rifampicin. The minimal
effective concentration for ethanol against all six strains was consistently 20% and was
completely eradicated isolates within 4 hours (Qu et al.).
Staphyloccocus aureus, Staphylococcus epidermis, Klebsiella pneumonia, Psuedomonas
aeruginosa, and Candida albicans were more effectively eradicated by a 60% ethanol solution
than by a 46.7% trisodium citrate solution (Balestrino et al., 2009). Trisodium citrate is not an
agent that is currently recommended against for clinical use per the CDC as of 2011. Although it
has shown to be efficacious in lowering the rate of catheter-related bloodstream infections, lifethreatening hypocalcemia, cardiac dysrhythmias, and death can occur if it is infused too rapidly
(CDC, 2011). Systemic side effects of ethanol lock therapy noted in clinical practice have
included dizziness, lightheadedness, and nausea (Dannenberg, Blerbach, Rothe, Beer, &
Korholz, 2003).
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An in vitro study by Venkatesh et al. (2009) compared ethanol (12.5%) to
Ethylenediaminetetraacetic acid (EDTA), N-acetylcysteine, and talactoferrin. The results of the
study indicated ethanol was also the most efficacious of the four agents in reducing the biomass
of S. epidermis (strain ATCC 55133). All four agents significantly reduced a polymicrobial film
consisting of S. epidermis (strain ATCC 55133) and Candida albicans (strain ATCC 32354); for
this biofilm, ethanol was the least efficacious of the four agents. Ethanol was the only agent of
the four listed above to significantly reduce Candida albicans (strain ATCC 32354) in
polymicrobial biofilms as compared to the control.
The in-vitro study by Chaudhury, Rangineni, and Venkatramana (2012) used eight
isolates of methicillin resistant staphylococci from colonized central venous catheters.
Gentamicin, ciprofloxacin, and vancomycin were each used in varying concentrations of 1,5, and
10 mg/mL and compared to ethanol in concentrations of 20%, 40%, and 80%. All of the isolates
were eradicated by the 40% ethanol solution within one hour. The isolates were not eradicated by
the gentamicin, ciprofloxacin, or vancomycin within a period of 24 hours.
According to the Infectious Disease Society of America, the efficacy rates of antibiotic
lock therapy vary. The efficacy rate was roughly 77 % in 21 open studies of antibiotic lock
therapy (Mermel et al., 2009). This is only a rough estimate, however, as the results will depend
upon the conditions in which the study is conducted. The most difficult organisms to treat with
antibiotic lock therapy are Candida albicans, a fungal infection, and Staphylococcus aureus. One
study reports only a 50% success rate in treating S. aureus with antibiotic lock therapy (Mermel
et al.). While there is some variance among studies, the efficacy of ethanol in treating existing
infection is usually comparable to antibiotic lock solutions or higher. Onland et al. (2006) found
a success rate of 88%, Cober et al. (2011) had a success rate of 73%, McGrath et al. (2011)
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showed an efficacy rate of 86%, and Valentine’s (2011) study in pediatric patients sterilized 92%
of the catheters.
Ethanol as a single agent shows significant promise, but further research is needed in
regard to the optimal concentration and dwell time. A concentration of 70% ethanol is the most
efficacious for topical antisepsis, which efficacy declining when concentrations over 70% are
used topically (Lehne, 2010). Further research is needed to see in ethanol instilled as a lock
solution follows these findings. In the in vitro study by Venkatesh et al. (2009), the authors
speculate that a concentration of ethanol >12.5 % may be more efficacious. The indications of
Dannenberg, et al. (2003), were that concentrations of ethanol used in clinical practice should be
over 40%. Most of the studies examined used ethanol in a concentration of 70% or lower. It
appears that a 100% concentration of ethanol may not be suitable for clinical use. One letter to
the editor citing use of 100% ethanol in three patients found that the high concentration caused
precipitation and occlusion of the line, necessitating removal (Laird, Soutar, & Butcher, 2005).
Catheter occlusion was noted in two other studies reviewed in this paper. Two catheters became
occluded in a study by Wales, et al. (2011). However, the number of catheter replacements
decreased from 5.6 ± 4.1 per 1000 catheter days to 0.3 ± 0.2 per 1000 catheter days. A study by
Kayton et al. (2010) was discontinued after three of the catheters became occluded. This may be
due in part to the overnight dwell time. Further research is needed to determine the optimal dwell
time and concentration of ethanol lock therapy, particularly when it is used prophylactically long
term.
Combinations of agents compared to ethanol as a single agent.
The in vitro study by Qu et al. (2009) also examined the efficacy of combinations of
antibiotics compared to ethanol. The combinations of antibiotics that were effective in
17

preventing regrowth of various strains of S. epidermis were gentamicin and rifampicin in a
concentration of 16:4 mcg/ml-1 (effective against one strain); gentamicin, vancomycin and
rifampicin in a concentration of 16:32:4 mcg/ml-1 (effective against one strain); and gentamicin,
ciprofloxacin, and rifampicin in a concentration of 16:4:4 mcg/ml-1 (effective against one
strain). The study also compared ethanol to single antibiotic lock agents, and found that a
concentration of 20% ethanol was found to be the minimal concentration efficacious against all
six strains.
Sherertz et al. (2006) compared the efficacy of ethanol, minocycline-edetate calcium
disodium (MEDTA), and taurolidine polyvinylpyrolidine against rifampin, ciprofloxacin,
vancomycin, and minocyline. In this study, ethanol was used as a single agent and compared to
antibiotic agents used both individually and in combination with one another. S. aureus was
more effectively eradicated by ethanol (3.6-3.9 log units of killing at 2 and 4 hours) compared to
all other single and combination lock agents.
Ethanol in combination with other agents compared to ethanol as a single agent.
Current studies indicate that ethanol may have a synergistic effect with antibiotics and
chelating agents such as ethylenediamineteteaacetic acid (EDTA) and trisodium citrate. A study
examining biofilm growth in vitro showed the regrowth of methicillin-resistant staphylococcus
aureus (MRSA) and C. parapsilosis was not completely prevented by 25% ethanol. However,
MRSA and C. parapsilosis organisms were completely eradicated and did not regrow after
exposure to a low concentration of ethanol (25%) used in conjunction with EDTA and
minocycline. This triple combination was found to be more effective than a combination of
minocycline and EDTA, minocycline in combination with 25% ethanol, EDTA in conjunction
with 25% ethanol, or 25% ethanol as a single agent (Raad, Hanna, Dvorak, Chaiban, & Hachem,
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2007). The concentration of ethanol was comparatively low, and more research is needed to see
if the effects of a higher concentration may yield different results. However, it appears that low
concentrations of ethanol may have a synergistic effect when used with minocycline and EDTA
(Raad et al.). According to an in vitro study by Takla, Zelenitsky, and Vercainge (2007), one
hour of exposure to a 30% ethanol, and 4% trisodium citrate lock solution also resulted in
eradication of MRSA, MSSA, MRSE, P. aeruginosa and E. coli. Nett, Guite, Ringeisen,
Holoyda, and Andres (2008) found that ethanol had a synergistic effect with fluconazole in
eradicating Candida albicans.
Ethanol may have a synergistic effect with antibiotics. In the in vitro study conducted by
Venkatesh et al. (2009), ethanol has been shown to have a synergistic effect with naficillin and
vancomycin in reducing three strains of S. epidermis. Synergistic effects between ethanol and
amphotericin B and ethanol combined with fluconazole were also noted in reducing the biomass
of two strains of Candida albicans (Venkatesh et al.).
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DISCUSSION
The purpose of this review was to compare the efficacies of ethanol lock therapy to
agents currently used for antimicrobial lock therapy and prophylaxis. The major finding of this
paper is that ethanol is as effective or more effective than the majority of antibiotic lock solutions
currently used to treat catheter-related bloodstream infections. Studies have shown that ethanol
lock therapy is effective in eradicating biofilms of organisms that frequently cause catheterrelated bloodstream infections, including Staphylococcus epidermis, Staphylococcus aureus,
Klebsiella pneumonia, Psuedomonas aeruginosa, E. coli, and Candida albicans (Chambers et
al., 2006). Ethanol also has a synergistic effect with other antimicrobial agents. A low
concentration of ethanol used in conjunction with other agents has been shown to be effective
against antibiotic resistant organisms such as MRSA (Raad et al., 2007). The cost of ethanol lock
therapy is significantly lower than antibiotic lock therapy, and ethanol lock therapy is generally
well tolerated by patients. Few side effects occurred systemically, and were limited to non-life
threatening side effects including nausea, taste of alcohol, and dizziness. Ethanol also has been
shown to have a synergistic effect when combined with antibiotics and antifungals in a lock
solution. When used prophylactically in patients experiencing recurring catheter-related
bloodstream infections, ethanol lock therapy has been shown to significantly lower the rate of
infection and the number of catheter replacements
The use of ethanol lock therapy appears relatively safe for clinical practice. Long-term
ethanol lock therapy does not appear to significantly alter the structure of silicone catheters, but
studies have indicated that it may alter the structure of polyurethane catheters. Many antibiotic
lock solutions will precipitate if the concentration is above the recommended level (Mermel et
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al., 2009) and the same phenomenon has been noted for ethanol lock therapy (Laird et al., 2005).
Catheter occlusion was noted in three studies reviewed in this paper. Catheter occlusion was not
noted when ethanol (in concentrations of 70% or less) was used short-term to treat active
infections, but appears more likely when high concentrations (over 70%) of ethanol are used or
during long-term prophylactic therapy. Further research is needed to determine the optimal
dwell time and concentration of ethanol lock therapy. Clinical studies are needed to establish the
safest and most effective guidelines for both ethanol lock prophylaxis and for ethanol lock
therapy for the treatment of active infections. Another area where further research is needed
concerns ethanol combined with anticoagulants. The CDC (2011) states that antibiotic locks are
usually combined with an anticoagulant such as heparin or EDTA. None of the studies presented
in this paper examined the use of ethanol combined with an anticoagulant in a clinical or in vivo
setting. The combination of EDTA and ethanol appears to be promising. EDTA has
anticoagulant properties (CDC) and has been shown to synergistically enhance the effects of
ethanol (Raad et al., 2007). Lastly, additional research on the sensitivity to various organisms to
ethanol is needed.
Indications for Clinical Use
Ethanol is an agent that has been shown to be effective in treating existing catheterrelated bloodstream infections in conjunction with systemic antibiotics. It has been shown to
have equal or greater efficacy to several antibiotic and antimicrobial agents used in practice and
should be considered as an agent for the treatment of catheter-related bloodstream infections. It
is effective when used as a single agent or when used in combination with other antimicrobial
agents. Clinical studies have shown that prophylactic ethanol lock therapy is effective in
reducing the rates of infection and catheter removal. Although the Infectious Diseases Society of
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America currently does not recommend routine prophylactic lock therapy using any agent,
ethanol lock prophylaxis may be of consideration in patients who have recurring catheter-related
bloodstream infections. It is recommended that cultures be obtained before beginning ethanol
lock therapy in order to determine that the causative organism is sensitive to ethanol. According
to the recommendations of the Infectious Diseases Society of America, 70% ethanol may be
considered for a mixed culture of Gram positive and Gram negative organisms (Mermel et al.,
2009).
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LIMITATIONS
The limitations of this study include the lack of extensive research comparing ethanol
lock therapy to existing lock solutions. Although there were numerous studies comparing
ethanol to a placebo such as heparinized saline, there were only a few studies comparing ethanol
to antibiotic or other antimicrobial lock agents currently used in clinical practice. Among the
studies found and cited throughout this review, the concentration of ethanol and antimicrobial
lock solutions varied with each study. Limitations for clinical practice include the lack of data
concerning the optimal concentration and dwell time. There is currently very little data
comparing combinations of antibiotic and antimicrobial lock therapies to ethanol as a single
agent. Culturing the organism before beginning ethanol lock therapy is necessary. There are
currently no evidenced-based guidelines for practitioners regarding the susceptibility of various
organisms to ethanol. The studies cited in this paper provide a starting point, but further research
is needed to determine guidelines for the use of ethanol lock therapy in clinical practice.
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FLOW DIAGRAM OF THE STUDY SELECTION PROCESS
Key search terms: catheter*, ethanol*
Inclusion criteria: English only, peer-reviewed, full-text only. No restrictions placed on
date of publication

Screening of relevant studies from the following databases: Academic Search
Premier, Web of Science, Biological Abstracts, CINAHL Plus with Full Text, and
MEDLINE.

Studies that did not meet the
inclusion criteria:
(n=1,531)

Studies retrieved for a more detailed review
(n=184)

Studies excluded after a more detailed review
due to not meeting inclusion criteria
(n=137)

Relevant studies meeting
all the inclusion criteria
(n=47)

Additional sources hand reviewed and
25
meeting inclusion criteria (n=3).
Total for review (n=50)

APPENDIX B: TABLE OF EVIDENCE
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TABLE OF EVIDENCE
Inclusion criteria: English only, peer-reviewed, full-text only. No restrictions placed on date of
publication. Includes the search terms: catheter* and ethanol*
Exclusion criteria: Articles not meeting the inclusion criteria listed above or pertaining to the use
of ethanol in central venous lines for uses other than catheter-related bloodstream infections (i.e.
prevention of occlusion).
Articles

Design

Findings

McGrath et al., 2011

Retrospective Seventy percent ethanol was instilled for 4 to
review
25 hour dwell times with systemic
antimicrobials. This study involved 59 pediatric
patients (ages 2 months to 19 years). There was
an 86% eradication rate for catheter-related
bloodstream infections and a central line
retention rate of 78%. The ethanol lock therapy
was tolerated well. This study has a 95%
confidence interval.

Bijo et al., 2011

Retrospective This retrospective study examined 31 adult
study
patients receiving home parenteral nutrition
from January 2006 to August 2009. Between
parenteral nutrition infusion cycles, the central
venous catheter was locked with 70% ethanol.
Admissions for catheter-related bloodstream
infections dropped from 273 prior to ethanol
lock therapy to 47 post-ethanol lock therapy.
The rate of catheter-related admissions was
10.1 per 1,000 catheter days prior to ethanol
lock therapy and 2.9 per 1,000 catheter days
after ethanol lock therapy. No side effects or
complications were reported.

Blackwood, Klein, Willers,
Mody, Teitebaum, & Cober,
2011

Case study

Ethanol lock therapy and systemic antifungals
were used for successful treatment of three
consecutive cases of catheter-related
bloodstream infection caused by Candida spp.

Chambers, Pithie, Gallagher,
Liu, Charles, & Seaward,

Animal trial

A double-blind animal trial was conducted
using a cross over design. The sheep were
catheterized twice, and for both times the
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2007

central venous lines were inoculated with S.
epidermis. One catheter was treated with
ethanol (70% and water), and the control was
heparinized normal saline. There were eight
days between placement of the first and second
central lines. After a three hour lock period,
sterilization was achieved in 9 of 11 catheters
using ethanol lock therapy, and in 0 of 11
catheters using heparinized saline.

Ackoundou-N’guessan et al.,
2006

Case study

A 60% ethanol lock solution was started on day
24 of a catheter-related bloodstream infection
of a 70 year old female with sepsis. The
causative organism was methicillin-resistant
Staphylococcus aureus. Previous treatment with
vaconocmycin and gentamycin were
unsuccessful and resulted in the removal of the
catheter on day 18. The catheter was changed
again on day 22 due to sepsis and catheter
dysfunction. The third catheter on day 24 was
locked with 60% ethanol. All subsequent blood
cultures were sterile. Lock technique was
stopped on day 53 with no adverse effects or
catheter dysfunction.

Crnich, Halfmann, Crone, &
Maki, 2005

In vitro study

Polyetherurethane and silicone catheters were
locked with a 70% ethanol solution for
approximately 10 weeks. Their integrity was
then compared to a control group of the same
catheters that were left empty and were not
filled with a lock solution. There was not a
statistically significant difference in force at
break between the ethanol-filled catheters and
the control group. There were slight differences
in elasticity and slight swelling of the walls of
the polyethurethane occurred when locked with
the ethanol solution for 10 weeks. These
measures were not affected in the silicone
catheters.

Genu et al., 2007

In vitro study

This in vitro study examined the effects of
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ethanol on the mechanical properties of silicone
catheters. For fifteen days, catheters were
locked with 0.9% sodium chloride, 95%
ethanol, and 60% ethanol. The catheters
immersed in 95% ethanol were examined using
scanning electron microscopy and did not have
any damage to the surfaces of the catheter.
Silicone was released from the catheter into the
solution. In contrast, the 60% ethanol did not
have any silicone released into the solution and
was comparable to the normal saline regardless
of exposure time.
Raad, Hanna, Dvorak,
Chaiban, & Hachem, 2007

In vitro
comparison
of the
efficacy of
25% ethanol,
minocycline,
EDTA, and
combinations
of the above
agents.

Ethanol may have a synergistic effect with
minocycline and EDTA. The most efficacious
agent in completely preventing regrowth of
MRSA and C. parapsilosis was a triple
combination of minocycline, EDTA, and 25%
ethanol.

Maharaj, Zelenitsky, &
Vercaigne, 2008

In vitro study

All isolates of Candida albicans were
eradicated within an hour exposure to a
combination of 30% ethanol and 4% trisodium
citrate.

Cober, Kovacevich, &
Teitelbaum, 2011

Retrospective This study examined the effects of long-term
study
prophylaxis using ethanol lock therapy in
pediatric patients. Out of 15 patients, 73%
remained infection free. The rate of catheter
repair was elevated after initiation of ethanol
lock therapy. The rate of BSI per 1,000 catheter
days was initially 8.0 and was 1.3 after ELT.
Noted side effects included one incidence of
thrombosis, difficulty withdrawing blood, and
increased need for repair of the device.

Heng, et al., 2011

Controlled
non-

This study noted an increase of 2-13% in
catheter dysfunction during short-term ethanol
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crossover
cohort study

lock therapy with tunneled silicon catheters.
Removal of the catheter was not necessary for
any of the 30 patients. Efficiency of dialysis
was not decreased.

Kayton et al., 2010

Clinical trial

A prophylactic 70% ethanol lock solution was
administered overnight to 12 pediatric patients.
This study was discontinued after three of the
catheters became occluded.

Sanders, et al. 2011

Clinical trial

This clinical trial conducted in Australia
examined the prophylactic use of a 70% ethanol
lock. Blood stream infections occurred in 9% of
the group receiving ethanol lock therapy and in
37% of the control group receiving heparinized
saline.

Shenep, et al., 2011

In vitro study

Seventy percent ethanol showed the greatest
antimicrobial activity within the shortest
incubation periods when compared to heparin
with preservative parabens or 0.9% benzyl
alcohol. The organisms used in the study were
Candida albicans, Pseudomonas aerguinosa,
Staphylococcus aureus, Escherichia coli,
Bacillus cereus, and Staphylococccus
epidermis.

Slobbe et al., 2010

Clinical trial

This study examined the prophylactic effect of
ethanol lock therapy. Patients were either
prophylactically given ethanol lock therapy or a
placebo. The rate of infection for patients who
received the ethanol locks prophylactically for
fifteen minutes daily was 0.70 per 1,000
catheter days. The authors conclude that there
was a non-significant reduction of 41%. For
the control group, the rate of infection was 1.19
per 1,000 catheter days. Side effects in the
experimental group included one episode of
syncope, taste of ethanol, and facial flushing.
One catheter in the experimental group was
removed due to rupture of one of the lumens.
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Sherertz, Boger, Collins,
Mason, & Raad, 2006

In vitro study

Valentine, 2011

Retrospective This study in pediatric patients aged 77 days
study
through 20 years. Twenty-six central venous
catheters were treated using a 70% ethanol
lock. Sterilization was achieved in 92% of
catheters. Single doses of ethanol lock therapy
were used in 13 of the catheter-related
bloodstream infections, and multiple doses
were required for the other infections.

Broom et al., 2008

Retrospective This study examined the efficacy of 70%
study
ethanol lock therapy in conjunction with
systemic antibiotics. The mean catheter
retention rate was 47 days and the median was
36 days in 15 out of 17 patients. The only side
effect noted was a patient described tasting
alcohol.

Qu, Istivan, Daley, Rouch, &
Deighton, 2009

Clinical in
vitro trial

Ethanol was more effective in eradicating
coagulase-negative staphylococci than
oxacillin, gentamicin, vancomycin,
ciprofloxacin, and rifampin.

Laird, Soutar, & Butcher,
2005.

Letter to the
editor,
clinical use

Use of 100% ethanol for 24 hrs. in 3 cases of
catheter related blood stream infections in a
Scottish hospital led to line precipitation and
occlusion leading to removal of the catheter.

Takla, Zelenitsky, &
Vercainge, 2007

In vitro trial

One hour of exposure to a 30% ethanol, and 4%
trisodium citrate lock solution resulted in
eradication of MRSA, MSSA, MRSE, P.
aeruginosa and E. coli.

Bell, Jayaraman, & Vercaigne, In vitro study
2006

Ethanol as a single agent was superior in
eliminating Staphylococcus aureus organisms
in 2-4 hours.

A 30% ethanol and 4% trisodium citrate
solution was locked into catheters for 9 days at
37 degrees Celsius. Less force was needed to
break the catheter that had been filled with the
ethanol and trisodium citrate solution than the
catheters filled with trisodium citrate or
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heparin. Elongation at break was also less for
the ethanol and trisodium filled catheters. The
ethanol and trisodium catheter After 9 weeks,
11.5 kg of force could be applied to the ethanol
and trisodium citrate locked catheter and the
ability to stretch after locking was to 22 times
the original length.
Jones et al., 2010

Retrospective The retrospective review examined the
review
prophylactic use of 70% ethanol lock therapy
three times a week in pediatric patients
receiving parenteral nutrition. The rate of
infection prior to initiation was 9.9 per 1,000
catheter days. During ethanol lock therapy, the
rate of infection was 2.1 per 1,000 catheter
days. The study’s population was 23 patients.

Balestrino et al., 2009

In vitro study

This trial compared 46.7% trisodium citrate to a
60% ethanol. The organisms used in the
comparison were Staphylococcus aureus, S.
epidermis, Klebsiella pneumonia, Psuedomonas
aeruginosa, and Candida albicans. TSC had a
significant bactericidal effect but did not fully
eradicate any sessile organisms of the above
bacteria. Twenty-four hour exposure to TSC
resulted in the eradication of P. aeruginosa. A
20-minute exposure to ethanol (60%) resulted
in eradication in all of the above planktonic
organisms.

Rajpurkar et al., 2009

Case studies
of three
patients with
hemophilia A
undergoing
ethanol lock
therapy.

Three cases of hemophilia A patients with
catheter-related bloodstream infections resistant
to vancomycin were treated using ethanol lock
therapy. The infections were eradicated in all
three patients with no noted side effects.

Mouw, Chessman, Lesher, &
Tagge, 2008

Retrospective This study examined the prophylactic use of
review
ethanol lock therapy in ten children with short
bowel syndrome who were receiving home
parenteral nutrition. Seventy percent ethanol
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was instilled daily for 4 to 14 hours. Five
patients had an initial period without
prophylactic ethanol lock therapy. The
incidence of infection during this time was
11.15 per 1,000 catheter days. When these
patients were placed on prophylactic ethanol
lock therapy, the incidence of infection was
2.06 per 1,000 catheter days. Five patients
received ethanol locker therapy throughout their
treatment, and had an infection rate of 1.85 per
1,000 catheter days. No adverse effects were
noted.
Onland, Shin, Fustar, Rushing, Retrospective Seventy percent ethanol was used in 40
& Wing-Yen, 2006
review
pediatric patients. Clearance of the organism
was achieved in 88% of the treated episodes.
Treatment was successful in 94% of
monomicrobial isolates and in 75% of
polymicrobial isolates.
Opila, Kirby, & Edmond,
2007

Retrospective This study examined the incidence of catheterreview
related bloodstream infections in nine patients
with recurring infections before and during
prophylactic ethanol lock therapy (25-70% with
a dwell time between 2-4 hours). The rate of
catheter changes prior to initiating therapy was
7.0 per 1,000 days. After prophylactic ethanol
lock therapy, this sample of patients
experienced 0.3 catheter changes per 1,000
days. The incidence of infection was 8.3 per
1,000 catheter days prior to initiating therapy
and 2.7 per 1,000 catheter days in this sample
of nine patients. Transient dizziness and nausea
were the only noted side effects.

Pomplun, Johnson, Johnston,
& Kolesar, 2007

In vitro study

This study examined the stability of 50%
ethanol stored in syringes at room temperature,
unprotected from light. A concentration of
47.08% was the mean for all samples older than
28 days. According to the author’s
interpretation, the findings of this study indicate
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that a stability period of 28 days is typical of
50% ethanol stored at room temperature.
Wales et al., 2011

Retrospective This study compared the rates of catheterreview
related bloodstream infection in 10 pediatric
patients dependent on parenteral nutrition
before and after receiving prophylactic ethanol
lock therapy. The rate prior to ethanol lock
therapy was 5.6 per 1,000 catheter days, and 0.3
per 1,000 catheter days after receiving ethanol
lock prophylaxis (70% ethanol). Two of the
catheters were removed due to thrombosis.
“Central venous catheter replacements also
decreased from 5.6 ± 4.1 per 1000 catheter days
to 0.3 ± 0.2 per 1000 catheter days after ethanol
lock therapy” (Wales et al., 2011).
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